Chronic low back pain affects 13% of American adults. A Texas physician explains what causes it, why imaging often misleads, and which evidence-based treatments actually work in 2026.
By Dr. Casey Dean, DO · Board-Certified Family Medicine Physician · Published 2026-05-21
Nearly 40% of American adults reported back pain in the past three months, according to the National Health Interview Survey — and for about 13% of them, that pain has become chronic, lasting 12 weeks or longer. If you've been dealing with a dull ache, stiffness, or sharp twinges in your lower back that just won't quit, you're not imagining it, and you're certainly not alone. Chronic low back pain is one of the single most common reasons Americans visit a primary care doctor, and it's a leading cause of missed workdays and disability worldwide. Yet despite how common it is, most people have never had a clear, honest conversation with a physician about what's actually causing it — and what the evidence says about treating it.
Here's what your doctor wants you to know.
In medicine, we draw a meaningful line between acute and chronic low back pain. Acute low back pain — the kind that shows up after you lift something awkward, sleep in a weird position, or overdo it at the gym — almost always resolves on its own. Studies consistently show that 70–90% of acute low back pain episodes improve within six weeks, regardless of treatment.
Acute low back pain typically lasts less than six weeks and most often resolves on its own — 70–90% of episodes improve regardless of treatment. Chronic low back pain is defined as pain persisting 12 weeks or longer. It involves changes in the nervous system, amplified pain signals, muscle deconditioning, and often psychological and lifestyle factors. The treatment approach is fundamentally different: acute pain may need only reassurance and brief activity modification, while chronic pain requires a comprehensive biopsychosocial plan.
MRIs often show disc bulges, arthritis, and degenerative changes in people with zero pain. Because these 'abnormalities' are common age-related findings, routine imaging is not recommended for nonspecific chronic low back pain without red flags. Imaging can actually worsen outcomes by increasing fear and activity avoidance. Your doctor will order an MRI only if you have neurologic deficits, red flag symptoms, or have failed conservative therapy.
The strongest evidence supports structured exercise (walking, core strengthening, yoga, tai chi, Pilates) as the single most effective intervention. First-line care also includes spinal manipulation, cognitive behavioral therapy (CBT), mindfulness-based stress reduction, acupuncture, massage, and heat therapy. NSAIDs like ibuprofen or naproxen are the first-choice medication when needed. Opioids, muscle relaxants, and surgery are not first-line treatments for nonspecific chronic low back pain.
Yes. Telehealth is well-suited for chronic low back pain evaluation and management. Your physician can take a detailed history, screen for red and yellow flags, review your medications, discuss lifestyle factors, and build a structured treatment plan — all via secure video. At Trinity Family Medicine, Texas patients see the same physician at every visit, which is especially valuable for chronic conditions requiring ongoing follow-up. Visits start at $49.
Yellow flags are psychosocial predictors of poor outcomes: depressed or anxious mood, fear-avoidance behavior (avoiding movement out of fear), catastrophic thinking ('my back is broken'), workplace dissatisfaction, and social isolation. These aren't signs of weakness — they're well-documented risk factors. Addressing them through CBT, graded activity programs, and support can reduce work absences by 50% and prevent progression to disability.
No — the evidence does not support acetaminophen (Tylenol) for chronic low back pain. Clinical trials show it performs no better than placebo for pain or function in this condition. NSAIDs (ibuprofen, naproxen) have the best evidence among over-the-counter options. Duloxetine (an SNRI antidepressant) has moderate evidence for small but meaningful improvement, especially when pain coexists with depression or anxiety.